We serve Chemical Name:5-(aminomethyl)-1,2-dihydro-1,2,4-triazol-3-one CAS:83160-78-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-(aminomethyl)-1,2-dihydro-1,2,4-triazol-3-one
CAS.NO:83160-78-5
Synonyms:5-(aminomethyl)-1,2-dihydro-1,2,4-triazol-3-one
Molecular Formula:C3H6N4O
Molecular Weight:114.10600
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:1.89g/cm3
Index of Refraction:1.801
PSA:87.56000
Exact Mass:114.05400
LogP:
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 5-(aminomethyl)-1,2-dihydro-1,2,4-triazol-3-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-(aminomethyl)-1,2-dihydro-1,2,4-triazol-3-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-(aminomethyl)-1,2-dihydro-1,2,4-triazol-3-one Use and application,5-(aminomethyl)-1,2-dihydro-1,2,4-triazol-3-one technical grade,usp/ep/jp grade.
Related News: Onconova has conducted trials with two other research compounds and has a pre-clinical program with a CDK4/6 and Ark5 inhibitor, ON 123300. 5-(aminomethyl)-1,2-dihydro-1,2,4-triazol-3-one manufacturer Onconova has conducted trials with two other research compounds and has a pre-clinical program with a CDK4/6 and Ark5 inhibitor, ON 123300. 5-(aminomethyl)-1,2-dihydro-1,2,4-triazol-3-one supplier Australia has started denying entry to all travelers who have come from or transited through mainland China. 5-(aminomethyl)-1,2-dihydro-1,2,4-triazol-3-one vendor Onconova has conducted trials with two other research compounds and has a pre-clinical program with a CDK4/6 and Ark5 inhibitor, ON 123300. 5-(aminomethyl)-1,2-dihydro-1,2,4-triazol-3-one factory AXON is planning a follow-up trial that will include a better-defined group of Alzheimer’s patients suffering from both amyloid plaques and tau tangles, Novak said.